Alcoholic Hepatitis Treatment Market Seeking Excellent Growth, Industry Report to 2028

Alcoholic hepatitis is a serious, inflammatory condition of the liver caused by excessive alcohol consumption over time. It is often exacerbated by heavy drinking and long-term alcohol use. Due to continuous drinking, some additional complications may occur in body such as cirrhosis, excessive bleeding, and even liver failure. When the liver is harmed, as a result of decades of heavy drinking, it can become inflamed, scarred, and fatty, and eventually may stop working properly. For instance, according to the American Liver Foundation 2017, alcoholic hepatitis affects only a small percentage of heavy drinkers in the U.S. that is not over 35%.

The common symptoms of alcoholic hepatitis include pain and swelling in abdomen, fatigue, weight loss, jaundice, nausea & vomiting, fever, easy bleeding, and bruising.

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/4485

If the alcoholic hepatitis is mild, stopping consumption of alcohol may help in reversing the disease. Changing the diet, which include intake of low-sodium foods along with diuretics and vitamin supplements, could be another form of treatment. Medication that reduces inflammation in the liver and improves liver function such as corticosteroids (pentoxifylline) may be used to treat alcoholic hepatitis. If the above-mentioned treatments do not work, owing to the disease progression, a liver transplant may be required.

The rising cases of alcohol use and deaths due to alcoholic hepatitis are expected to propel the growth of global alcoholic hepatitis treatment market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2018, 25.1% of adults aged 18 and above had at least one heavy drinking day (five or more drinks for men and four or more drinks for women) in the U.S. Moreover, in 2019, 24,110 people died as a result of alcoholic liver disease in the U.S.

Moreover, increasing product launches and approvals is expected to boost global alcoholic hepatitis treatment market growth. For instance, on December 16, 2020, Durect Corporation announced that DUR-928 was granted fast track designation by the U.S. Food and Drug Administration (FDA) for the treatment of alcoholic hepatitis. Durect is a biopharmaceutical company dedicated to transforming the treatment of acute organ injury and chronic liver diseases through the development of novel, potentially lifesaving therapies. DUR-928, Durect's lead drug candidate, is an endogenous sulfated oxysterol and an epigenetic regulator with a distinct mechanism of action. Epigenetic regulators are compounds that control gene expression patterns without altering the DNA sequence. These factors are expected to support global alcoholic hepatitis treatment market growth over the forecast period.

Major Market Competitors

Apotex Inc., Gilead Sciences Inc., Johnson & Johnson Services Inc., Alkermes plc , Mallinckrodt Pharmaceuticals, Durect Corporation , Novartis AG, Teva Pharmaceutical Industries Ltd., Aventis Pharma Ltd., and Cipla Ltd.

For Customization on this Report @
https://www.coherentmarketinsights.com/insight/request-customization/4485

Global Alcoholic Hepatitis Treatment Market – Taxonomy

By Drug Class:

Corticosteroids
Hemorheologic Agents
Monoclonal Antibodies
Anabolic Steroids
Others
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:

North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Frequently Asked Questions?

What will the market size be in 2028?

What are the key factors driving the European market?

What are the challenges to market growth?

Who are the key players in the market?

What are the market opportunities and threats faced by the key players?

What will be the growth rate in 2028?

Which strategies are used by top players in the Alcoholic Hepatitis Treatment Market?

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/4485

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.